Synopsis

Cardio-Oncology is a new and rapidly expanding clinical field that challenges traditional treatment paradigms in helping a vulnerable population. Cardiovascular complications of novel chemotherapeutics are increasingly recognized and can affect nearly any dimension of cardiac function. Therefore there is a need for versatile cardiac imaging techniques which can guide physicians be looking beyond traditional imaging biomarkers, such as LVEF. Cardiovascular MRI is well-positioned to meet these challenges. This session will introduce the current landscape of cardio-oncology and how cardiovascular MRI may help.